You are here

antivirals

Study: Gilead antiviral drug shows promise as a treatment for Ebola Sudan

Stat

Thu, 03/14/24 - 06:25 pm

Gilead Sciences

Millions of doses of Pfizer's Paxlovid will go to waste in UK, EU as COVID demand plummets

Fierce Pharma

Tue, 01/2/24 - 10:08 pm

Study suggests Covid rebound is far more common with Paxlovid than without

Stat

Mon, 11/13/23 - 10:57 pm

Pfizer's COVID-19 Oral Antiviral Treatment Transitioning from Government Distribution

Drugs.com

Sun, 11/5/23 - 11:10 pm

HHS pledges to keep Paxlovid available as it transitions to commercial market

The Hill

Tue, 10/17/23 - 09:34 pm

Gilead pays $100M for first dibs on all Assembly Bio assets, bolting antiviral engine to its R&D group

Fierce Biotech

Tue, 10/17/23 - 10:27 am

Gilead Sciences

Assembly Biosciences

U.S. orders antiviral drugs worth $138 million from SIGA Tech

Reuters

Sat, 07/29/23 - 10:39 pm

SIGA technologies

Pardes Biosciences changes hands (sort of) in wake of COVID-19 trial fail

Fierce Biotech

Mon, 07/17/23 - 09:34 am

Pardes Biosciences

FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults

CNBC

Thu, 05/25/23 - 08:28 pm

Biotech launched during Covid — for Covid — looks for strategic alternatives after antiviral fails PhII trial

Endpoints

Mon, 04/3/23 - 10:42 pm

Pardes Biosciences

FDA adcomm votes in favor of Pfizer's Covid-19 pill Paxlovid

Endpoints

Thu, 03/16/23 - 06:18 pm

FDA staff report says data shows Pfizer’s Covid treatment Paxlovid is effective in high-risk adults

CNBC

Tue, 03/14/23 - 06:26 pm

Merck asks EMA to reevaluate rejected Covid-19 antiviral

Endpoints

Mon, 03/13/23 - 04:40 pm

Merck pill linked to new mutations, study says

Fierce Pharma

Thu, 02/2/23 - 11:15 pm

Gilead nixes Matinas oral COVID-19 antiviral to focus on late-phase internal program

Fierce Biotech

Wed, 02/1/23 - 10:30 am

Gilead Sciences

Matinas BioPharma

Pfizer's search for Paxlovid's COVID-busting sibling leads to low-profile antiviral biotech

Fierce Biotech

Tue, 12/6/22 - 10:41 am

Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck

Fierce Pharma

Tue, 11/22/22 - 04:28 pm

FDA Cites ‘Uncertainties’ in Veru's COVID-19 Antiviral Data Ahead of Adcomm

BioSpace

Tue, 11/8/22 - 10:57 am

FDA chief stands by Paxlovid nod amid discussion on 'rebound' cases

Fierce Pharma

Wed, 11/2/22 - 10:18 am

Siga nabs $10.7M from the US government in deal for its monkeypox antiviral

Endpoints

Thu, 09/29/22 - 07:36 pm

SIGA technologies

Pages